News & Insights

How Many 1572s Is Too Many?

Cutting Through the Confusion Around Repeated Form FDA 1572 Updates Do you find yourself asking this question every time you’re asked to resubmit a Form FDA 1572? Is it being clearly explained as to why it was requested – and what happens if you push back on the request? It’s

Read More »

Budgets Built on Assumptions Will Break in Reality 

Clinical trial budgets often look great — on paper. But when they hit real-world sites, they collapse under the weight of missing context:  📍 Geography — “Standard” travel budgets don’t work in rural regions with limited transit. 👥 Diversity — Reaching underrepresented communities takes trust-building, time, and staff — none

Read More »

Why Don’t CROs and Sponsors Collaborate More with Research Sites?

This is the most overlooked partnership in clinical research — and it shows.  Despite being the front line of study execution, research sites are rarely consulted in protocol design, startup planning, or technology rollouts.  And yet… when timelines slip or recruitment lags, the question becomes: “Why aren’t the sites performing?” 

Read More »